{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:56:08Z","timestamp":1791053768230,"version":"4.1.0"},"reference-count":58,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Se\u0301zary syndrome (SzS) is an advanced form of cutaneous T-cell lymphoma associated with involvement of the peripheral blood by malignant T cells. The disease is defined by impaired cell-mediated immunity and the production of interferon-\u03b3 (IFN-\u03b3) and interleukin-2 (IL-2), possibly as a result of deficient IL-12 production. To understand the mechanism of this impairment, we examined the composition and function of dendritic cells and monocytes in the blood of SzS patients with different levels of peripheral blood tumor burden. Consistent with our previous observations, numbers of monocytes in SzS patients were comparable to numbers observed in healthy donors. In contrast, decreased IL-12 production correlated with a decrease in the numbers of CD11c+ dendritic cells, which was particularly profound among patients with medium (20%-50% circulating malignant T cells) and high (more than 50% circulating malignant T cells) tumor burden. Furthermore, CD123+ dendritic cells, major producers of IFN-\u03b1, were significantly diminished in SzS patients, regardless of the level of tumor burden. Granulocyte macrophage\u2013colony-stimulating factor\u2013treated patients experienced an increase in the number of dendritic cells but not in IFN-\u03b1 or IL-12 production. However, in vitro stimulation of peripheral blood mononuclear cells from SzS patients with rCD40L and IFN-\u03b3 significantly increased the production of IL-12. Thus, our results demonstrate a profound defect in circulating dendritic cells in SzS patients that may contribute to the pathogenesis of the cytokine disorders and to the depressed cellular immunity. Importantly, the ability of rCD40L to potently induce IL-12 production from monocytes and residual dendritic cells of SzS patients could potentially serve as an immune-restorative therapeutic agent.<\/jats:p>","DOI":"10.1182\/blood-2002-01-0231","type":"journal-article","created":{"date-parts":[[2002,10,16]],"date-time":"2002-10-16T23:03:08Z","timestamp":1034809388000},"page":"3287-3294","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":62,"title":["Se\u0301zary syndrome patients demonstrate a defect in dendritic cell populations: effects of CD40 ligand and treatment with GM-CSF on dendritic cell numbers and the production of cytokines"],"prefix":"10.1182","volume":"100","author":[{"given":"Maria","family":"Wysocka","sequence":"first","affiliation":[{"name":"From the Department of Dermatology, University of Pennsylvania, Philadelphia; the Department of Dermatology, Geneva University Hospital, Switzerland; and The Wistar Institute, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed H.","family":"Zaki","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology, University of Pennsylvania, Philadelphia; the Department of Dermatology, Geneva University Hospital, Switzerland; and The Wistar Institute, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars E.","family":"French","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology, University of Pennsylvania, Philadelphia; the Department of Dermatology, Geneva University Hospital, Switzerland; and The Wistar Institute, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihed","family":"Chehimi","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology, University of Pennsylvania, Philadelphia; the Department of Dermatology, Geneva University Hospital, Switzerland; and The Wistar Institute, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Shapiro","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology, University of Pennsylvania, Philadelphia; the Department of Dermatology, Geneva University Hospital, Switzerland; and The Wistar Institute, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne E.","family":"Everetts","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology, University of Pennsylvania, Philadelphia; the Department of Dermatology, Geneva University Hospital, Switzerland; and The Wistar Institute, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen S.","family":"McGinnis","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology, University of Pennsylvania, Philadelphia; the Department of Dermatology, Geneva University Hospital, Switzerland; and The Wistar Institute, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Montaner","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology, University of Pennsylvania, Philadelphia; the Department of Dermatology, Geneva University Hospital, Switzerland; and The Wistar Institute, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain H.","family":"Rook","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology, University of Pennsylvania, Philadelphia; the Department of Dermatology, Geneva University Hospital, Switzerland; and The Wistar Institute, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111617422375500_B1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0190-9622(80)80385-9","article-title":"Cutaneous T cell lymphoma: mycosis fungoides, Se\u0301zary syndrome, and other variants.","volume":"2","author":"Edelson","year":"1980","journal-title":"J Am Acad Dermatol."},{"key":"2019111617422375500_B2","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1172\/JCI110062","article-title":"Cell surface differentiation antigens of the malignant T cell in Se\u0301zary syndrome and mycosis fungoides.","volume":"67","author":"Haynes","year":"1981","journal-title":"J Clin Invest."},{"key":"2019111617422375500_B3","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archderm.1993.01680250098016","article-title":"The immunopathogenesis of cutaneous T-cell lymphoma: abnormal cytokine production by Se\u0301zary T cells.","volume":"129","author":"Rook","year":"1993","journal-title":"Arch Dermatol."},{"key":"2019111617422375500_B4","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/1523-1747.ep12326693","article-title":"Th2 cytokine profile in cutaneous T-cell lymphoma.","volume":"105","author":"Lessin","year":"1995","journal-title":"J Invest Dermatol."},{"key":"2019111617422375500_B5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/1523-1747.ep12611877","article-title":"Aberrant cytokine production by Se\u0301zary syndrome patients: cytokine secretion pattern resembles murine Th2 cells.","volume":"99","author":"Vowels","year":"1992","journal-title":"J Invest Dermatol."},{"key":"2019111617422375500_B6","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/1523-1747.ep12398454","article-title":"Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma.","volume":"103","author":"Vowels","year":"1994","journal-title":"J Invest Dermatol."},{"key":"2019111617422375500_B7","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.4049\/jimmunol.154.3.1491","article-title":"IL-12 reverses cytokine and immune abnormalities in Se\u0301zary syndrome.","volume":"154","author":"Rook","year":"1995","journal-title":"J Immunol."},{"key":"2019111617422375500_B8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0065-2776(08)60387-9","article-title":"Interleukin-12: a cytokine at the interface of inflammation and immunity.","volume":"70","author":"Trinchieri","year":"1998","journal-title":"Adv Immunol."},{"key":"2019111617422375500_B9","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1084\/jem.184.2.747","article-title":"Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation.","volume":"184","author":"Cella","year":"1996","journal-title":"J Exp Med."},{"key":"2019111617422375500_B10","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/eji.1830250442","article-title":"Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction.","volume":"25","author":"Shu","year":"1995","journal-title":"Eur J Immunol."},{"key":"2019111617422375500_B11","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/30996","article-title":"Help for cytotoxic T-cell responses is mediated by CD40 signalling.","volume":"393","author":"Bennett","year":"1998","journal-title":"Nature."},{"key":"2019111617422375500_B12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4049\/jimmunol.158.1.359","article-title":"Antigen-driven but not lipopolysaccharide-driven IL-12 production in macrophages requires triggering of CD40.","volume":"158","author":"DeKruyff","year":"1997","journal-title":"J Immunol."},{"key":"2019111617422375500_B13","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/eji.1830260216","article-title":"CD40\/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages.","volume":"26","author":"Kennedy","year":"1996","journal-title":"Eur J Immunol."},{"key":"2019111617422375500_B14","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/eji.1830260732","article-title":"Accessory signaling by CD40 for T cell activation: induction of Th1 and Th2 cytokines and synergy with interleukin-12 for interferon-gamma production.","volume":"26","author":"Peng","year":"1996","journal-title":"Eur J Immunol."},{"key":"2019111617422375500_B15","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/31002","article-title":"T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.","volume":"393","author":"Schoenberger","year":"1998","journal-title":"Nature."},{"key":"2019111617422375500_B16","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/00002371-200103000-00011","article-title":"Proinflammatory cytokines and CD40 ligand enhance cross-presentation and cross-priming capability of human dendritic cells internalizing apoptotic cancer cells.","volume":"24","author":"Hoffmann","year":"2001","journal-title":"J Immunother."},{"key":"2019111617422375500_B17","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.4049\/jimmunol.161.5.2094","article-title":"Dendritic cells require maturation via CD40 to generate protective antitumor immunity.","volume":"161","author":"Mackey","year":"1998","journal-title":"J Immunol."},{"key":"2019111617422375500_B18","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1006\/smim.1998.0147","article-title":"CD40-CD40 ligand interactions and their role in cytotoxic T lymphocyte priming and anti-tumor immunity.","volume":"10","author":"Toes","year":"1998","journal-title":"Semin Immunol."},{"key":"2019111617422375500_B19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity.","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature."},{"key":"2019111617422375500_B20","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1146\/annurev.immunol.18.1.767","article-title":"Immunobiology of dendritic cells.","volume":"18","author":"Banchereau","year":"2000","journal-title":"Annu Rev Immunol."},{"key":"2019111617422375500_B21","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.4049\/jimmunol.163.6.3250","article-title":"Survival, maturation, and function of CD11c\u2212 and CD11c+ peripheral blood dendritic cells are differentially regulated by cytokines.","volume":"163","author":"Kohrgruber","year":"1999","journal-title":"J Immunol."},{"key":"2019111617422375500_B22","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1002\/(SICI)1521-4141(199909)29:09<2769::AID-IMMU2769>3.0.CO;2-2","article-title":"Human peripheral blood contains two distinct lineages of dendritic cells.","volume":"29","author":"Robinson","year":"1999","journal-title":"Eur J Immunol."},{"key":"2019111617422375500_B23","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.4049\/jimmunol.154.10.5071","article-title":"Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells.","volume":"154","author":"Macatonia","year":"1995","journal-title":"J Immunol."},{"key":"2019111617422375500_B24","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1126\/science.283.5405.1183","article-title":"Reciprocal control of T helper cell and dendritic cell differentiation.","volume":"283","author":"Rissoan","year":"1999","journal-title":"Science."},{"key":"2019111617422375500_B25","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1084\/jem.185.6.1101","article-title":"The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand.","volume":"185","author":"Grouard","year":"1997","journal-title":"J Exp Med."},{"key":"2019111617422375500_B26","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/11360","article-title":"Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon.","volume":"5","author":"Cella","year":"1999","journal-title":"Nat Med."},{"key":"2019111617422375500_B27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1084\/jem.192.2.219","article-title":"Natural interferon alpha\/beta-producing cells link innate and adaptive immunity.","volume":"192","author":"Kadowaki","year":"2000","journal-title":"J Exp Med."},{"key":"2019111617422375500_B28","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1126\/science.284.5421.1835","article-title":"The nature of the principal type 1 interferon-producing cells in human blood.","volume":"284","author":"Siegal","year":"1999","journal-title":"Science."},{"key":"2019111617422375500_B29","first-page":"131","article-title":"Cutaneous T-cell lymphoma.","volume":"1","author":"Murphy","year":"1988","journal-title":"Adv. Pathol."},{"key":"2019111617422375500_B30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/sj.jidsp.5640188","article-title":"Photopheresis: clinical applications and mechanism of action.","volume":"4","author":"Rook","year":"1999","journal-title":"J Investig Dermatol Symp Proc."},{"key":"2019111617422375500_B31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/1097-0320(20010215)46:1<33::AID-CYTO1035>3.0.CO;2-S","article-title":"Flow cytometric analysis of cytokine production by normal human peripheral blood dendritic cells and monocytes: comparative analysis of different stimuli, secretion-blocking agents and incubation periods.","volume":"46","author":"Bueno","year":"2001","journal-title":"Cytometry."},{"key":"2019111617422375500_B32","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0145-2126(00)00022-9","article-title":"Disruption of the IFN-gamma cytokine network in chronic lymphocytic leukemia contributes to resistance of leukemic B cells to apoptosis.","volume":"24","author":"Zaki","year":"2000","journal-title":"Leuk Res."},{"key":"2019111617422375500_B33","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1073\/pnas.90.8.3539","article-title":"Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.","volume":"90","author":"Dranoff","year":"1993","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111617422375500_B34","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1084\/jem.176.6.1693","article-title":"Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte\/macrophage colony-stimulating factor.","volume":"176","author":"Inaba","year":"1992","journal-title":"J Exp Med."},{"key":"2019111617422375500_B35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0163-7258(93)90021-5","article-title":"Human natural interferon-alpha producing cells.","volume":"60","author":"Fitzgerald-Bocarsly","year":"1993","journal-title":"Pharmacol Ther."},{"key":"2019111617422375500_B36","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.4049\/jimmunol.168.9.4796","article-title":"Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals.","volume":"168","author":"Chehimi","year":"2002","journal-title":"J Immunol."},{"key":"2019111617422375500_B37","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.4049\/jimmunol.166.3.2141","article-title":"Deficient IL-12(p35) gene expression by dendritic cells derived from neonatal monocytes.","volume":"166","author":"Goriely","year":"2001","journal-title":"J Immunol."},{"key":"2019111617422375500_B38","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1182\/blood.V86.2.646.bloodjournal862646","article-title":"Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-gamma of lipopolysaccharide-inducible p35 and p40 genes.","volume":"86","author":"Hayes","year":"1995","journal-title":"Blood."},{"key":"2019111617422375500_B39","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1182\/blood.V83.7.1847.1847","article-title":"Differential regulation of interleukin-12 (IL-12), tumor necrosis factor alpha, and IL-1 beta production in human myeloid leukemia cell lines and peripheral blood mononuclear cells.","volume":"83","author":"Kubin","year":"1994","journal-title":"Blood."},{"key":"2019111617422375500_B40","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1084\/jem.183.1.147","article-title":"The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells.","volume":"183","author":"Ma","year":"1996","journal-title":"J Exp Med."},{"key":"2019111617422375500_B41","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.0022-202x.2001.01354.x","article-title":"Dysregulation of lymphocyte interleukin-12 receptor expression in Se\u0301zary syndrome.","volume":"117","author":"Zaki","year":"2001","journal-title":"J Invest Dermatol."},{"key":"2019111617422375500_B42","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.4049\/jimmunol.163.7.4073","article-title":"Depressed IL-12\u2013mediated signal transduction in T cells from patients with Se\u0301zary syndrome is associated with the absence of IL-12 receptor beta 2 mRNA and highly reduced levels of STAT4.","volume":"163","author":"Showe","year":"1999","journal-title":"J Immunol."},{"key":"2019111617422375500_B43","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.4049\/jimmunol.160.4.1701","article-title":"CD40 ligand\/CD40 stimulation regulates the production of IFN-gamma from human peripheral blood mononuclear cells in an IL-12\u2013 and\/or CD28- dependent manner.","volume":"160","author":"McDyer","year":"1998","journal-title":"J Immunol."},{"key":"2019111617422375500_B44","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1046\/j.1365-3083.1999.00491.x","article-title":"Phenotypic and functional properties of dendritic cells isolated from human peripheral blood in comparison with mononuclear cells and T cells.","volume":"49","author":"Huang","year":"1999","journal-title":"Scand J Immunol."},{"key":"2019111617422375500_B45","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1084\/jem.189.3.521","article-title":"Type I interferons keep activated T cells alive.","volume":"189","author":"Marrack","year":"1999","journal-title":"J Exp Med."},{"key":"2019111617422375500_B46","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1126\/science.8009221","article-title":"Functional role of type I and type II interferons in antiviral defense.","volume":"264","author":"Muller","year":"1994","journal-title":"Science."},{"key":"2019111617422375500_B47","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/11303","article-title":"Linking innate and adaptive immunity.","volume":"5","author":"Palucka","year":"1999","journal-title":"Nat Med."},{"key":"2019111617422375500_B48","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.4049\/jimmunol.157.11.4781","article-title":"Activation of STAT4 by IL-12 and IFN-alpha: evidence for the involvement of ligand-induced tyrosine and serine phosphorylation.","volume":"157","author":"Cho","year":"1996","journal-title":"J Immunol."},{"key":"2019111617422375500_B49","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/79747","article-title":"Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization.","volume":"1","author":"Cella","year":"2000","journal-title":"Nat Immunol."},{"key":"2019111617422375500_B50","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0889-8588(18)30060-1","article-title":"Interferon in the treatment of cutaneous T-cell lymphoma.","volume":"9","author":"Olsen","year":"1995","journal-title":"Hematol Oncol Clin North Am."},{"key":"2019111617422375500_B51","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1182\/blood.V92.11.4238","article-title":"Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factor.","volume":"92","author":"Brossart","year":"1998","journal-title":"Blood."},{"key":"2019111617422375500_B52","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4049\/jimmunol.165.1.566","article-title":"Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo.","volume":"165","author":"Pulendran","year":"2000","journal-title":"J Immunol."},{"key":"2019111617422375500_B53","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1084\/jem.179.4.1109","article-title":"Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte\/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.","volume":"179","author":"Sallusto","year":"1994","journal-title":"J Exp Med."},{"key":"2019111617422375500_B54","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.4049\/jimmunol.154.8.3821","article-title":"Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily.","volume":"154","author":"Zhou","year":"1995","journal-title":"J Immunol."},{"key":"2019111617422375500_B55","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1084\/jem.192.12.1785","article-title":"Generation of interferon alpha-producing predendritic cell (Pre-DC)2 from human CD34(+) hematopoietic stem cells.","volume":"192","author":"Blom","year":"2000","journal-title":"J Exp Med."},{"key":"2019111617422375500_B56","doi-asserted-by":"crossref","first-page":"F39","DOI":"10.1084\/jem.192.12.F39","article-title":"Will the making of plasmacytoid dendritic cells in vitro help unravel their mysteries?","volume":"192","author":"Banchereau","year":"2000","journal-title":"J Exp Med."},{"key":"2019111617422375500_B57","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1182\/blood.V94.3.902.415k23_902_908","article-title":"Interleukin-12 therapy of cutaneous T-cell lymphoma induces lesion regression and cytotoxic T-cell responses.","volume":"94","author":"Rook","year":"1999","journal-title":"Blood."},{"key":"2019111617422375500_B58","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1073>3.0.CO;2-R","article-title":"Induction of human tumor-loaded dendritic cells.","volume":"91","author":"Berger","year":"2001","journal-title":"Int J Cancer."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/100\/9\/3287\/1257594\/h82102003287.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/100\/9\/3287\/1257594\/h82102003287.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T19:38:09Z","timestamp":1682365089000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/100\/9\/3287\/16387\/Sezary-syndrome-patients-demonstrate-a-defect-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11,1]]},"references-count":58,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2002,11,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2002-01-0231","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2002,11,1]]}}}